$A mathematical model of the impact of novel treatments on the A\03B2 burden in the Alzheimer's brain, CSF and plasma$

A mathematical model of the impact of novel treatments on the A\03B2 burden in the Alzheimer's brain, CSF and plasma

Title from cover.

Bibliographic Details
Main Authors:	Wein, Lawrence M., Craft, David Lee, Selkoe, Dennis J.
Other Authors:	Sloan School of Management.
Format:	Working Paper
Published:	[Cambridge, Mass. : Alfred P. Sloan School of Management, Massachusetts Institute of Technology] 2009
Online Access:	http://hdl.handle.net/1721.1/48375

Similar Items

The impact of novel treatments on A\03B2 burden in Alzheimer's Disease : insights from a mathematical model
by: Craft, David Lee., et al.
Published: (2009)

The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
by: Westwood, S, et al.
Published: (2017)

Association of CSF biomarkers with MRI brain changes in Alzheimer's disease
by: Nazib M Seidu, et al.
Published: (2024-01-01)

Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’ disease biomarkers
by: Anna Orduña Dolado, et al.
Published: (2024-06-01)

The amyloid hypothesis of Alzheimer's disease at 25 years
by: Dennis J Selkoe, et al.
Published: (2016-03-01)

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease
by: Anna Hofmann, et al.
Published: (2024-11-01)

Decreased CSF acetylcholinesterase activity in Alzheimer's disease.
by: Appleyard, M, et al.
Published: (1983)

Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
by: Sofia Bergström, et al.
Published: (2021-07-01)

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
by: Delvenne, A, et al.
Published: (2024)

Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
by: Rik Ossenkoppele, et al.
Published: (2021-07-01)

Identifying novel proteins underlying bipolar disorder via integrating pQTLs of the plasma, CSF, and brain with GWAS summary data
by: Zhehao Xiao, et al.
Published: (2024-08-01)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
by: Eleonora M. Vromen, et al.
Published: (2022-01-01)

Differential diagnosis of mild cognitive impairment of Alzheimer’s disease by Simoa p-tau181 measurements with matching plasma and CSF
by: Ling Wu, et al.
Published: (2024-01-01)

Putative novel CSF biomarkers of Alzheimer’s disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort
by: Alessandra Bigi, et al.
Published: (2024-03-01)

Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
by: Westwood, S, et al.
Published: (2020)

Correlation of psychomotor retardation with plasma G-CSF and M-CSF levels in patients with major depressive disorder
by: Geng Yanhong, et al.
Published: (2023-12-01)

Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease
by: Carol Van Hulle, et al.
Published: (2024-01-01)

Cortical folding correlates to aging and Alzheimer’s Disease’s cognitive and CSF biomarkers
by: Fernanda Hansen P. de Moraes, et al.
Published: (2024-02-01)

Inflammation-related plasma and CSF biomarkers for multiple sclerosis
by: Huang, J, et al.
Published: (2020)

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
by: Ashton, NJ, et al.
Published: (2019)

Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
by: Combrinck, M, et al.
Published: (2006)

Editorial: CSF clearance in Alzheimer's disease and related dementias: exploring mechanisms and implications
by: Yi Li
Published: (2025-03-01)

Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease
by: Marjan Assefi, et al.
Published: (2024-04-01)

The longitudinal trajectory of CSF sTREM2: the alzheimer’s disease neuroimaging initiative
by: Yu Wang, et al.
Published: (2024-06-01)

Potential prognostic value of CSF-targeted proteomics across the Alzheimer’s disease continuum
by: Bingdong Xu, et al.
Published: (2024-06-01)

CSF protein ratios with enhanced potential to reflect Alzheimer’s disease pathology and neurodegeneration
by: Sára Mravinacová, et al.
Published: (2024-02-01)

Fat droplets in the cerebrospinal fluid (CSF) spaces of the brain
by: Mark Reed, et al.
Published: (2024-11-01)

Dipeptides in CSF and plasma: diagnostic and therapeutic potential in neurological diseases
by: Katharina Küper, et al.
Published: (2024-12-01)

Novel αβ Integrin-Targeted Peptide Probes for Prostate Cancer Imaging
by: Chiun-Wei Huang, et al.
Published: (2011-07-01)

The increasing burden of Alzheimer disease.
by: Sadik, K, et al.
Published: (2003)

A three‐range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease
by: Wagner S. Brum, et al.
Published: (2022-01-01)

Glymphatic system clearance and Alzheimer’s disease risk: a CSF proteome-wide study
by: Natalia Cullell, et al.
Published: (2025-01-01)

Nasal lymphatic obstruction of CSF drainage as a possible cause of Alzheimer’s disease and dementia
by: William Thomas Phillips, et al.
Published: (2024-10-01)

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2017-07-01)

Predicting Alzheimer's disease CSF core biomarkers: a multimodal Machine Learning approach
by: Anna Michela Gaeta, et al.
Published: (2024-06-01)

Pathophysiological subtypes of mild cognitive impairment due to Alzheimer’s disease identified by CSF proteomics
by: Daniela Moutinho, et al.
Published: (2024-04-01)

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease
by: Nicolai Franzmeier, et al.
Published: (2024-01-01)

The Role of CSF Transthyretin in Human Alzheimer's Disease: Offense, Defense, or not so Innocent Bystander
by: Joel N. Buxbaum
Published: (2023-11-01)

Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington’s disease mice
by: Nicholas S. Caron, et al.
Published: (2024-10-01)

Aqueductal CSF stroke volume is associated with the burden of perivascular space enlargement in chronic adult hydrocephalus
by: Pasquale Gallina, et al.
Published: (2024-06-01)